ImmunityBio, Inc 10-Q for FY2022 Q3
ImmunityBio, Inc. (IBRX)
10-Q
2022-11-09
For: 2022-09-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on November 9, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $118K
- up 78.8% from $66K a year earlier
- Net loss
- $110.94M
- compared with a net loss of $87.63M a year earlier
- Diluted EPS
- -$0.28
- compared with -$0.22 a year earlier